Ginna Laport Selected Research

Hematologic Neoplasms (Hematological Malignancy)

1/2019

Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ginna Laport Research Topics

Disease

4	Neoplasms (Cancer) 01/2020 - 11/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019
1	Lymphoma (Lymphomas) 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Circulating Neoplastic Cells 01/2012
1	Breast Neoplasms (Breast Cancer) 01/2012
1	Multiple Myeloma 12/2011
1	Disease Progression 12/2011
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2010
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2010

Drug/Important Bio-Agent (IBA)

1	Immune Checkpoint InhibitorsIBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2019
1	trans-crotonin (CTN)IBA 12/2011
1	Rituximab (Mabthera)FDA Link 04/2010

Therapy/Procedure

4	Cell Transplantation 01/2019 - 11/2017
3	Therapeutics 01/2020 - 04/2010
2	Hematopoietic Stem Cell Transplantation 01/2019 - 04/2010
1	Immunotherapy 01/2020
1	Homologous Transplantation 01/2019
1	Lymphatic Irradiation 01/2019
1	Drug Therapy (Chemotherapy) 01/2012
1	Transplantation 01/2012
1	Stem Cell Transplantation 12/2011
1	Salvage Therapy 04/2010